Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
A revisit to the effect of annealing temperature on magnetic properties of LaFe [electronic resource] by
- Dutta, Uma
- Ghosh, Debamalya
- Haque, Ariful
- Kumar, Lalit
- Mandal, Tapas Kumar
- Walke, Pravin S
- Pal, Kamalesh
- Gayen, Arup
- Kundu, Asish K
- Seikh, Md Motin
Publication details: Journal of physics. Condensed matter : an Institute of Physics journal Jun 2019
In:
Journal of physics. Condensed matter : an Institute of Physics journal vol. 31
Availability: No items available.
|
|
10.
|
Initial molecular response at 3 months may predict both response and event-free survival at 24 months in imatinib-resistant or -intolerant patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase treated with nilotinib. [electronic resource] by
- Branford, Susan
- Kim, Dong-Wook
- Soverini, Simona
- Haque, Ariful
- Shou, Yaping
- Woodman, Richard C
- Kantarjian, Hagop M
- Martinelli, Giovanni
- Radich, Jerald P
- Saglio, Giuseppe
- Hochhaus, Andreas
- Hughes, Timothy P
- Müller, Martin C
Producer: 20130506
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|
|
11.
|
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase. [electronic resource] by
- Hughes, Timothy
- Saglio, Giuseppe
- Branford, Susan
- Soverini, Simona
- Kim, Dong-Wook
- Müller, Martin C
- Martinelli, Giovanni
- Cortes, Jorge
- Beppu, Lan
- Gottardi, Enrico
- Kim, Dongho
- Erben, Philipp
- Shou, Yaping
- Haque, Ariful
- Gallagher, Neil
- Radich, Jerald
- Hochhaus, Andreas
Producer: 20090915
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|
|
12.
|
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. [electronic resource] by
- Saglio, Giuseppe
- Kim, Dong-Wook
- Issaragrisil, Surapol
- le Coutre, Philipp
- Etienne, Gabriel
- Lobo, Clarisse
- Pasquini, Ricardo
- Clark, Richard E
- Hochhaus, Andreas
- Hughes, Timothy P
- Gallagher, Neil
- Hoenekopp, Albert
- Dong, Mei
- Haque, Ariful
- Larson, Richard A
- Kantarjian, Hagop M
Producer: 20100622
In:
The New England journal of medicine vol. 362
Availability: No items available.
|
|
13.
|
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance. [electronic resource] by
- Kantarjian, Hagop M
- Giles, Francis
- Gattermann, Norbert
- Bhalla, Kapil
- Alimena, Giuliana
- Palandri, Francesca
- Ossenkoppele, Gert J
- Nicolini, Franck-Emmanuel
- O'Brien, Stephen G
- Litzow, Mark
- Bhatia, Ravi
- Cervantes, Francisco
- Haque, Ariful
- Shou, Yaping
- Resta, Debra J
- Weitzman, Aaron
- Hochhaus, Andreas
- le Coutre, Philipp
Producer: 20080109
In:
Blood vol. 110
Availability: No items available.
|